Lipid profiles in schizophrenia associated with clinical traits: a five year follow-up study
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Lipid profiles in schizophrenia associated with clinical traits: a five year follow-up study
Authors
Keywords
Schizophrenia, Membrane Lipid, Serum Lipid, Lipid Level, Antipsychotic Medication
Journal
BMC Psychiatry
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-08-25
DOI
10.1186/s12888-016-1006-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Membrane Damage Induced by Amyloid Beta and a Potential Link with Neuroinflammation
- (2016) Eduardo J. Fernandez-Perez et al. CURRENT PHARMACEUTICAL DESIGN
- Biomarkers for drug development in early psychosis: Current issues and promising directions
- (2016) Donald C. Goff et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review
- (2016) M O Trépanier et al. MOLECULAR PSYCHIATRY
- Inflammatory evidence for the psychosis continuum model
- (2016) Ragni H. Mørch et al. PSYCHONEUROENDOCRINOLOGY
- In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [11C]DPA-713 PET and analysis of CSF and plasma
- (2016) J M Coughlin et al. Translational Psychiatry
- Association between serum lipids and membrane fatty acids and clinical characteristics in patients with schizophrenia
- (2015) D. K. Solberg et al. ACTA PSYCHIATRICA SCANDINAVICA
- C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications
- (2015) B S Fernandes et al. MOLECULAR PSYCHIATRY
- Neuroinflammation and white matter pathology in schizophrenia: systematic review
- (2015) Souhel Najjar et al. SCHIZOPHRENIA RESEARCH
- Polyunsaturated fatty acid–phospholipid remodeling and inflammation
- (2015) Philippe Pierre Robichaud et al. Current Opinion in Endocrinology Diabetes and Obesity
- The Science of Fatty Acids and Inflammation
- (2015) Kevin L Fritsche Advances in Nutrition
- Oxidized cholesterol as the driving force behind the development of Alzheimer’s disease
- (2015) Paola Gamba et al. Frontiers in Aging Neuroscience
- The role of inflammation in schizophrenia
- (2015) Norbert Müller et al. Frontiers in Neuroscience
- Abundant Genetic Overlap between Blood Lipids and Immune-Mediated Diseases Indicates Shared Molecular Genetic Mechanisms
- (2015) Ole A. Andreassen et al. PLoS One
- Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity
- (2014) J. Assies et al. ACTA PSYCHIATRICA SCANDINAVICA
- Oxidative Stress and Psychological Disorders
- (2014) Samina Salim Current Neuropharmacology
- Associations of oxidative stress status parameters with traditional cardiovascular disease risk factors in patients with schizophrenia
- (2014) Bojana Vidović et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Impaired Metabolic Reactivity to Oxidative Stress in Early Psychosis Patients
- (2014) Margot Fournier et al. SCHIZOPHRENIA BULLETIN
- Improved Detection of Common Variants Associated with Schizophrenia by Leveraging Pleiotropy with Cardiovascular-Disease Risk Factors
- (2013) Ole A. Andreassen et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Lipidomics Reveals Early Metabolic Changes in Subjects with Schizophrenia: Effects of Atypical Antipsychotics
- (2013) Joseph McEvoy et al. PLoS One
- Long-chain polyunsaturated fatty acids (LCPUFA) from genesis to senescence: The influence of LCPUFA on neural development, aging, and neurodegeneration
- (2013) Carola I.F. Janssen et al. PROGRESS IN LIPID RESEARCH
- Free radicals, antioxidant defense systems, and schizophrenia
- (2013) Jing Qin Wu et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Altered phospholipid metabolism in schizophrenia: A phosphorus 31 nuclear magnetic resonance spectroscopy study
- (2013) Wolfgang Weber-Fahr et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- RETRACTED: Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients
- (2013) Jagadeesh Sridhara Rao et al. SCHIZOPHRENIA RESEARCH
- Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder
- (2013) Sigrun Hope et al. SCHIZOPHRENIA RESEARCH
- A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia
- (2013) H Bentsen et al. Translational Psychiatry
- Inflammatory Markers in Hyperlipidemia: From Experimental Models to Clinical Practice
- (2012) Gerasimos Siasos et al. CURRENT PHARMACEUTICAL DESIGN
- Potential biomarkers in psychiatry: focus on the cholesterol system
- (2012) Alisa G. Woods et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Schizophrenia is primed for an increased expression of depression through activation of immuno-inflammatory, oxidative and nitrosative stress, and tryptophan catabolite pathways
- (2012) George Anderson et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Clinical and biochemical validation of two endophenotypes of schizophrenia defined by levels of polyunsaturated fatty acids in red blood cells
- (2012) H. Bentsen et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Impaired plasmalogens in patients with schizophrenia
- (2012) Rima Kaddurah-Daouk et al. PSYCHIATRY RESEARCH
- Red blood cell polyunsaturated fatty acids measured in red blood cells and schizophrenia: A meta-analysis
- (2012) Wendela P. Hoen et al. PSYCHIATRY RESEARCH
- A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia
- (2012) W.J.M. van der Kemp et al. SCHIZOPHRENIA RESEARCH
- Cardiovascular risk factors during second generation antipsychotic treatment are associated with increased C-reactive protein
- (2012) Ingrid Dieset et al. SCHIZOPHRENIA RESEARCH
- Bimodal Distribution of Polyunsaturated Fatty Acids in Schizophrenia Suggests Two Endophenotypes of the Disorder
- (2011) Håvard Bentsen et al. BIOLOGICAL PSYCHIATRY
- The symptom and function dimensions of the Global Assessment of Functioning (GAF) scale
- (2011) Geir Pedersen et al. COMPREHENSIVE PSYCHIATRY
- Cholesterol and cognition in schizophrenia: A double-blind study of patients randomized to clozapine, olanzapine and haloperidol
- (2011) Menahem Krakowski et al. SCHIZOPHRENIA RESEARCH
- Anti-oxidant properties of high-density lipoprotein and atherosclerosis
- (2010) Eugene A Podrez CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Oxidative stress in schizophrenia: An integrated approach
- (2010) Byron K.Y. Bitanihirwe et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Lipid peroxidation in patients with schizophrenia
- (2010) Anna Dietrich-Muszalska et al. PSYCHIATRY AND CLINICAL NEUROSCIENCES
- Membrane fatty acid levels as a predictor of treatment response in chronic schizophrenia
- (2010) Tomiki Sumiyoshi et al. PSYCHIATRY RESEARCH
- Metabolic Risk Factors in Drug-Naive Patients With First-Episode Psychosis
- (2009) Swapna K. Verma et al. JOURNAL OF CLINICAL PSYCHIATRY
- Oxidative stress and metabolic syndrome
- (2009) Christian K. Roberts et al. LIFE SCIENCES
- Abnormal transbilayer distribution of phospholipids in red blood cell membranes in schizophrenia
- (2009) Philippe Nuss et al. PSYCHIATRY RESEARCH
- Fatty acids and oxidative stress in psychiatric disorders
- (2008) Sofia Tsaluchidu et al. BMC Psychiatry
- High Throughput Lipidomic Profiling of Schizophrenia and Bipolar Disorder Brain Tissue Reveals Alterations of Free Fatty Acids, Phosphatidylcholines, and Ceramides
- (2008) Emanuel Schwarz et al. JOURNAL OF PROTEOME RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search